FRANCO GARCIA: Open Payments
NPI 1780203653 · VALENCIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$510 in 18 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $510
Food & beverage: $510
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $238 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $107 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Amgen Inc. | 2 | $29 |
| Lilly USA, LLC | 1 | $25 |
| Hologic Sales and Service, LLC | 1 | $25 |
| PFIZER INC. | 1 | $24 |
| Exact Sciences Corporation | 1 | $15 |
| ViiV Healthcare Company | 1 | $14 |
Products named: Ozempic, JARDIANCE, Kerendia, OTEZLA, MOUNJARO, APTIMA, PAXLOVID, The Cologuard Plus Collection Kit.
Industry payments across CA — which companies pay providers there.
